Article
AbbVie Receives Orphan Drug and Fast Track Designations from the U.S. Food and Drug Administration
Rating:
0.0
Views:
45
Likes:
1
Library:
1
NORTH CHICAGO, Ill., Sept. 28, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug and Fast Track designations for
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value